Sabna Abdalla

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Signaling Pathway

Lipopolysaccharide Induced

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Shilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, Amal A Akour, Niraj Kumar Jha, Shreesh Kumar Ojha, Bassem Sadek
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Shilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, Amal A Akour, Niraj Kumar Jha, Shreesh Kumar Ojha, Bassem Sadek
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Shilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, Amal A Akour, Niraj Kumar Jha, Shreesh Kumar Ojha, Bassem Sadek
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Sabna Abdalla, Nermin Eissa, Petrilla Jayaprakash, Rami Beiram, Kamil J Kuder, Dorota Łażewska, Katarzyna Kieć-Kononowicz, Bassem Sadek
The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice. International journal of molecular sciences 24 (16) (2023)